(Q29006414)

English

Relvar Ellipta

pharmaceutical product

In more languages

default for all languages

No label defined

No description defined

Statements

pharmaceutical product

1 reference

European Medicines Agency product number

EMEA/H/C/002673

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002673/human_med_001708.jsp

22 March 2017

1 reference

European Medicines Agency product number

EMEA/H/C/002673

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002673/human_med_001708.jsp

22 March 2017

has active ingredient

fluticasone furoate/vilanterol

1 reference

European Medicines Agency product number

EMEA/H/C/002673

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002673/human_med_001708.jsp

22 March 2017

therapeutic area

chronic obstructive pulmonary disease

European Medicines Agency

13 November 2013

1 reference

European Medicines Agency product number

EMEA/H/C/002673

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002673/human_med_001708.jsp

16 February 2017

European Medicines Agency

Identifiers

European Medicines Agency product number

EMEA/H/C/002673

1 reference

European Medicines Agency product number

EMEA/H/C/002673

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002673/human_med_001708.jsp

22 March 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29006414&oldid=2012948237"